The Anti-inflammatory and antifibrosis effects of anthocyanin extracted from black soybean on a peyronie disease rat model

Urology

Volumn 84, Issue 5, 2014, Pages 1112-1116

  Kim, Sae Woong ^a   Sohn, Dong Wan ^a   Bae, Woong Jin ^a   Kim, Hyo Sin ^a   Kim, Sun Wook ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; COLLAGEN; FIBRIN GLUE; SOYBEAN EXTRACT; TRANSFORMING GROWTH FACTOR BETA1; ANTIINFLAMMATORY AGENT; TGFB1 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONNECTIVE TISSUE; CONTROL GROUP; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG ACTIVITY; EXPERIMENTAL ANIMAL; FIBROBLAST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PEYRONIE DISEASE; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; SOYBEAN; STAINING; STOMACH TUBE; TREATMENT DURATION; TRICHOME; TUNICA ALBUGINEA; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; PENILE INDURATION; PENIS; SPRAGUE DAWLEY RAT;

ANIMALS; ANTHOCYANINS; ANTI-INFLAMMATORY AGENTS; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; HUMANS; INFLAMMATION; MALE; PENILE INDURATION; PENIS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84908352403     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.06.026     Document Type: Article

References (27)

1. U. Schwarzer, F. Sommer, and T. Klotz The prevalence of Peyronie's disease: results of a large survey BJU Int 88 2001 727 730
2. J.P. Mulhall, S.D. Creech, and S.A. Boorjian Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening J Urol 171 2004 2350 2353
3. C.J. Devine Jr., K.D. Somers, and S.G. Jordan Proposal: trauma as the cause of the Peyronie's lesion J Urol 157 1997 285 290
4. J.P. Jarow, and F.C. Lowe Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction J Urol 158 1997 1388 1390
5. C. Hu, J. Zawistowski, and W. Ling Black rice (Oryza sativa L. indica) pigmented fraction suppresses both reactive oxygen species and nitric oxide in chemical and biological model systems J Agric Food Chem 51 2003 5271 5277
6. H.M. Kim, C.S. Kang, and E.H. Lee The evaluation of the antianaphylactic effect of Oryza sativa L. subsp. hsien Ting in rats Pharmacol Res 40 1999 31 36
7. S.J. Han, S.N. Ryu, and H.T. Trinh Metabolism of cyanidin-3-O-beta-D-glucoside isolated from black colored rice and its antiscratching behavioral effect in mice J Food Sci 74 2009 H253 258
8. H.H. Davila, M.G. Ferrini, and J. Rajfer Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease BJU Int 91 2003 830 838
9. A.I. El-Sakka, H.M. Hassoba, and R.M. Chui An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression J Urol 158 1997 2284 2290
10. A.I. El-Sakka, M.U. Hassan, and L. Nunes Histological and ultrastructural alterations in an animal model of Peyronie's disease Br J Urol 81 1998 445 452
11. W. Weidner, E.W. Hauck, and J. Schnitker Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study Eur Urol 47 2005 530 535 discussion 535-536
12. J. Pryor, and C. Farell Controlled clinical trial of vitamin E in Peyronie's disease Prog Reprod Biol Med 9 1983 41 45
13. M. Lemourt Oliva, E. Filgueiras López, and A. Rodríguez Barroso Clinical evaluation of the use of propoleum in Peyronie's disease Arch Esp Urol 51 1998 171 176
14. C. Teloken, E.L. Rhoden, and T.M. Grazziotin Tamoxifen versus placebo in the treatment of Peyronie's disease J Urol 162 1999 2003 2005
15. G. Biagiotti, and G. Cavallini Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report BJU Int 88 2001 63 67
16. M.R. Safarinejad, S.Y. Hosseini, and A.A. Kolahi Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study J Urol 178 2007 1398 1403 discussion 1403
17. M.R. Safarinejad Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: a prospective, randomized, double-blind placebo-controlled study J Sex Med 6 2009 1743 1754
18. M.G. Ferrini, I. Kovanecz, and G. Nolazco Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease BJU Int 97 2006 625 633
19. J.M. Kong, L.S. Chia, and N.K. Goh Analysis and biological activities of anthocyanins Phytochemistry 64 2003 923 933
20. D. Boivin, M. Blanchette, and S. Barrette Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice Anticancer Res 27 2007 937 948
21. A.M. Amorini, G. Lazzarino, and F. Galvano Cyanidin-3-O-beta-glucopyranoside protects myocardium and erythrocytes from oxygen radical-mediated damages Free Radic Res 37 2003 453 460
22. J.M. Tall, N.P. Seeram, and C. Zhao Tart cherry anthocyanins suppress inflammation-induced pain behavior in rat Behav Brain Res 153 2004 181 188
23. U.S. Ha, J.S. Koh, and H.S. Kim Cyanidin-3-O-β-D-glucopyranoside concentrated materials from mulberry fruit have a potency to protect erectile function by minimizing oxidative stress in a rat model of diabetic erectile dysfunction Urol Int 88 2012 470 476
24. K.D. Somers, and D.M. Dawson Fibrin deposition in Peyronie's disease plaque J Urol 157 1997 311 315
25. N.F. Gonzalez-Cadavid, and J. Rajfer Experimental models of Peyronie's disease. Implications for new therapies J Sex Med 6 2009 303 313
26. N.F. Gonzalez-Cadavid, and J. Rajfer Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy Nat Rev Urol 7 2010 215 221
27. E.G. Valente, D. Vernet, and M.G. Ferrini L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures Nitric Oxide 9 2003 229 244